← Back to Discover
TAKEDA PHARMACEUTICAL CO LTD
Period ended Sep 30, 2025 · Latest filing Nov 13, 2025
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Sep 30, 2025: $16,369,175
More quarters will appear as history becomes available.
Top holdings
Top 10 at Sep 30, 2025. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- Ovid Therapeutics, Inc. · COM · 690469101 · shares: $9,791,595
- Equillium, Inc. · COM · 29446K106 · shares: $2,609,717
- Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) · COM · 98422T100 · shares: $1,243,084
- Shattuck Labs, Inc. · COM · 82024L103 · shares: $1,232,329
- Lyell Immunopharma, Inc. · COM · 55083R104 · shares: $891,365
- American Well Corporation · COM · 03044L204 · shares: $478,061
- Rani Therapeutics Holdings, Inc. · COM · 753018100 · shares: $101,554
- Standard Biotools, Inc. · COM · 34385P108 · shares: $21,470
Reported holdings
9 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| Ovid Therapeutics, Inc. | COM | 690469101 | — | 5,750,000 shares | $7,475,000 |
| Equillium, Inc. | COM | 29446K106 | — | 1,824,977 shares | $2,609,717 |
| Ovid Therapeutics, Inc. | COM | 690469101 | — | 1,781,996 shares | $2,316,595 |
| Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics) | COM | 98422T100 | — | 1,475,121 shares | $1,243,084 |
| Shattuck Labs, Inc. | COM | 82024L103 | — | 515,619 shares | $1,232,329 |
| Lyell Immunopharma, Inc. | COM | 55083R104 | — | 54,887 shares | $891,365 |
| American Well Corporation | COM | 03044L204 | — | 77,733 shares | $478,061 |
| Rani Therapeutics Holdings, Inc. | COM | 753018100 | — | 203,190 shares | $101,554 |
| Standard Biotools, Inc. | COM | 34385P108 | — | 16,515 shares | $21,470 |